Serina Therapeutics Statistics
Total Valuation
SER has a market cap or net worth of $29.50 million. The enterprise value is $8.14 million.
Important Dates
The last earnings date was Thursday, May 14, 2026, after market close.
| Earnings Date | May 14, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
SER has 14.90 million shares outstanding. The number of shares has increased by 18.27% in one year.
| Current Share Class | 14.90M |
| Shares Outstanding | 14.90M |
| Shares Change (YoY) | +18.27% |
| Shares Change (QoQ) | +12.97% |
| Owned by Insiders (%) | 9.14% |
| Owned by Institutions (%) | 3.17% |
| Float | 8.36M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 226.92 |
| Forward PS | n/a |
| PB Ratio | 2.33 |
| P/TBV Ratio | 2.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 62.63 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 4.18, with a Debt / Equity ratio of 0.18.
| Current Ratio | 4.18 |
| Quick Ratio | 3.87 |
| Debt / Equity | 0.18 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -60.81 |
Financial Efficiency
Return on equity (ROE) is -221.93% and return on invested capital (ROIC) is -134.20%.
| Return on Equity (ROE) | -221.93% |
| Return on Assets (ROA) | -89.79% |
| Return on Invested Capital (ROIC) | -134.20% |
| Return on Capital Employed (ROCE) | -116.63% |
| Weighted Average Cost of Capital (WACC) | 5.00% |
| Revenue Per Employee | $10,000 |
| Profits Per Employee | -$1.66M |
| Employee Count | 13 |
| Asset Turnover | 0.01 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, SER has paid $25,000 in taxes.
| Income Tax | 25,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -63.40% in the last 52 weeks. The beta is 0.04, so SER's price volatility has been lower than the market average.
| Beta (5Y) | 0.04 |
| 52-Week Price Change | -63.40% |
| 50-Day Moving Average | 1.95 |
| 200-Day Moving Average | 3.30 |
| Relative Strength Index (RSI) | 56.86 |
| Average Volume (20 Days) | 81,894 |
Short Selling Information
The latest short interest is 293,855, so 1.97% of the outstanding shares have been sold short.
| Short Interest | 293,855 |
| Short Previous Month | 478,077 |
| Short % of Shares Out | 1.97% |
| Short % of Float | 3.51% |
| Short Ratio (days to cover) | 1.41 |
Income Statement
In the last 12 months, SER had revenue of $130,000 and -$21.52 million in losses. Loss per share was -$2.01.
| Revenue | 130,000 |
| Gross Profit | -13.03M |
| Operating Income | -24.44M |
| Pretax Income | -21.27M |
| Net Income | -21.52M |
| EBITDA | -24.37M |
| EBIT | -24.44M |
| Loss Per Share | -$2.01 |
Full Income StatementBalance Sheet
The company has $24.53 million in cash and $3.17 million in debt, with a net cash position of $21.36 million or $1.43 per share.
| Cash & Cash Equivalents | 24.53M |
| Total Debt | 3.17M |
| Net Cash | 21.36M |
| Net Cash Per Share | $1.43 |
| Equity (Book Value) | 17.63M |
| Book Value Per Share | 0.85 |
| Working Capital | 20.13M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$18.20 million and capital expenditures -$84,000, giving a free cash flow of -$18.29 million.
| Operating Cash Flow | -18.20M |
| Capital Expenditures | -84,000 |
| Depreciation & Amortization | 74,000 |
| Net Borrowing | 4.91M |
| Free Cash Flow | -18.29M |
| FCF Per Share | -$1.23 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -18,803.08% |
| Pretax Margin | -16,358.46% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
SER does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -18.27% |
| Shareholder Yield | -18.27% |
| Earnings Yield | -72.95% |
| FCF Yield | -61.98% |
Analyst Forecast
The average price target for SER is $11.00, which is 455.56% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $11.00 |
| Price Target Difference | 455.56% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | 95.53% |
| EPS Growth Forecast (5Y) | -9.10% |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |
